Page last updated: 2024-09-04

sk&f 83959 and amphetamine

sk&f 83959 has been researched along with amphetamine in 1 studies

Compound Research Comparison

Studies
(sk&f 83959)
Trials
(sk&f 83959)
Recent Studies (post-2010)
(sk&f 83959)
Studies
(amphetamine)
Trials
(amphetamine)
Recent Studies (post-2010) (amphetamine)
9404613,0713291,977

Protein Interaction Comparison

ProteinTaxonomysk&f 83959 (IC50)amphetamine (IC50)
Phenylethanolamine N-methyltransferaseBos taurus (cattle)0.96
Cytochrome P450 2A6Homo sapiens (human)3.5
Cytochrome P450 2A5Mus musculus (house mouse)2.85
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.96
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.96

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, T; George, SR; Perreault, ML; Shen, MY1

Other Studies

1 other study(ies) available for sk&f 83959 and amphetamine

ArticleYear
The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
    Pharmacology, biochemistry, and behavior, 2015, Volume: 128

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Male; Motor Activity; Multiprotein Complexes; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward

2015